Net Income for Moderna (MRNA)
According to Moderna's latest reported financial statements, the company's current net income (TTM) is -$2.82B USD. Net income is the bottom-line profit after all expenses — cost of goods sold, operating expenses, interest, and taxes — are subtracted from revenue. It is the figure used to compute earnings per share (EPS) and is the residual available to shareholders.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
MRNA
Currently viewingNet IncomeSwitch metric
TTM (last 4 quarters)
-$2.82B
YoY change
-20.8%
5Y CAGR
N/A
Peak year (2021)
$12.20B
Cumulative net income
$7.35B
Net Income history chart for Moderna (MRNA) from 2016 to 2025
Net Income history table for Moderna (MRNA) from 2016 to 2025
| Fiscal year | Period ended | Reported | Net Income | YoY |
|---|---|---|---|---|
| 2025 | -$2.82B | -20.8% | ||
| 2024 | -$3.56B | -24.5% | ||
| 2023 | -$4.71B | -156.4% | ||
| 2022 | $8.36B | -31.5% | ||
| 2021 | $12.20B | -1733.3% | ||
| 2020 | -$747.06M | +45.3% | ||
| 2019 | -$514.02M | +33.6% | ||
| 2018 | -$384.73M | +50.3% | ||
| 2017 | -$255.92M | +18.4% | ||
| 2016 | -$216.21M | — |
Net Income values are taken from Moderna's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
2025's annual net income for Moderna (MRNA) came in at -$2.82B – declined 20.8% year-over-year.
Moderna net income peaked at $12.20B in 2021; the latest annual figure is -$2.82B in 2025 (123.1% below peak).
The dataset's maximum net income sits at $12.20B (2021); the minimum reading of -$4.71B dates to 2023.
Moderna (MRNA) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $15.15B.
Moderna Net Income by Year
Moderna Net Income 2025: -$2.82B
Moderna net income in 2025 was -$2.82B, declined 20.8% below 2024.
Moderna Net Income 2024: -$3.56B
Moderna net income in 2024 was -$3.56B, declined 24.5% below 2023.
Moderna Net Income 2023: -$4.71B
Moderna net income in 2023 was -$4.71B, plunged 156.4% below 2022. This figure represents the lowest annual value in the available history.
Moderna Net Income 2022: $8.36B
Moderna net income in 2022 was $8.36B, plunged 31.5% below 2021.
Moderna Net Income 2021: $12.20B
Moderna net income in 2021 was $12.20B.
See more financial history for Moderna (MRNA).
Sector peers — Net Income
Companies in the same sector as Moderna, ranked by their latest net income.
| Company | Net Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $102.43B | Healthcare |
| Johnson & Johnson (JNJ) | $26.80B | Healthcare |
| Eli Lilly and Company (LLY) | $20.64B | Healthcare |
| Merck & Co., Inc. (MRK) | $18.25B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $12.06B | Healthcare |
| AstraZeneca PLC (AZN) | $10.26B | Healthcare |
| Amgen Inc. (AMGN) | $7.71B | Healthcare |
| AbbVie Inc. (ABBV) | $4.23B | Healthcare |
Frequently asked questions
What is Moderna's net income?
- Latest reported net income for Moderna (MRNA) is -$2.82B (period ending December 31, 2025).
How has Moderna net income changed year-over-year?
- Moderna (MRNA) net income changed -20.8% year-over-year on the latest annual filing.
When did Moderna net income hit its highest annual value?
- Moderna net income reached its highest annual value of $12.20B in 2021.
What was Moderna net income in 2024?
- Moderna (MRNA) net income in 2024 was -$3.56B.
What was Moderna net income in 2025?
- Moderna (MRNA) net income in 2025 was -$2.82B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
MRNA Overview
Company profile, financial tools, and key metrics
MRNA Revenue Counter
Earns $61.61 every second. See per minute, hour, and day.
MRNA Earnings Counter
Loses −$89.49 per second. See per minute, hour, and day.
MRNA Economic Scale
Exceeds Timor-Leste's GDP. Compare with world economies.
MRNA What If Invested
What if you had invested $1,000? See historical returns from any date.
MRNA How It Makes Money
Discover visual breakdown of $1.94B in revenue — where it comes from and where it goes.
MRNA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
MRNA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
MRNA Daily Price Character
Explosive · 48.2% historical win rate (green days). Streaks & record days.
MRNA Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.